We synthesized FGA from commercially available 2-deoxy-2-[
18F]fluoro-D-glucose (FDG). The pre-formulation data leading up to a kit has been published elsewhere [11 (
link)]. A typical kit vial contained a lyophilized mixture of 0.8 mg of 2,2,6,6-tetramethyl-1-piperidinyloxy or
TEMPO (Sigma-Aldrich, St. Louis, MO), 8 mg of sodium bromide (NaBr, Mallinckrodt, Paris, Kentucky, USA), and 24 mg sodium bicarbonate (NaHCO
3, Sigma-Aldrich). For conversion of FDG into FGA, FDG was introduced into the vial in presence of 20 μL
NaOCl (14% available chlorine, Alfa Aesar, Tewksbury, MA). After 5 min, the reaction was stopped and the mixture was neutralized by 1.5 mL of 0.2 M hydrochloric acid (HCl). The resultant product was drawn into a syringe for injection via a 0.2 μm syringe filter. The presence of FGA and FDG in the final preparation was monitored by thin-layered chromatography (TLC) as described elsewhere [11 (
link)].
Houson H., Mdzinarishvili A., Gali H., Sidorov E, & Awasthi V. (2020). PET detection of cerebral necrosis using an infarct-avid agent 2-deoxy-2-[18F]fluoro-D-glucaric acid (FGA) in a mouse model of the brain stroke. Molecular imaging and biology, 22(5), 1353-1361.